Report cover image

Smart Insulin Pens Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Oct 01, 2024
Length 125 Pages
SKU # FOB19260752

Description

Smart Insulin Pens Market



Growth Factors of Smart Insulin Pens Market

The global smart insulin pens market size was valued at USD 755.4 million in 2023 and is projected to grow from USD 824.9 million in 2024 to USD 1,913.6 million by 2032, exhibiting a CAGR of 11.1% during the forecast period of 2024-2032.

The COVID-19 pandemic disrupted the Smart Insulin Pens Market through supply chain delays but simultaneously accelerated the call because of an extra cognizance of remote healthcare. Patients sought virtual fitness solutions, using growth as smart insulin pens enabled higher glucose management and real-time facts sharing, impeding the smart insulin pens market growth.

The growing occurrence of diabetes drives the Smart Insulin Pens Market, multiplied patient recognition, and the ease of precise dosing and information sharing with healthcare companies. Technological advancements and mobile app integration for real-time tracking also enhance patient compliance and treatment results, fueling an increase in the marketplace.

Automated injection structures are a significant advancement in the clever insulin pen marketplace. These systems lessen the hazard of human error by appropriately turning in insulin doses, making sure of particular and steady treatment, and expanding the smart insulin pens market share globally. Additionally, automated injection systems provide extra comfort and simplicity of use for patients, mainly those with dexterity troubles or who might also find manual injections challenging. This generation contributes to progressed glycemic control and standard diabetes control.

Comprehensive Analysis of Smart Insulin Pens Market

The Smart Insulin Pens Market is segmented with connectivity, indication, and distribution channels. Connectivity includes Bluetooth, which dominates because of its wide adoption and flexibility, and NFC, which is predicted to develop thanks to more suitable protection functions. Indication segments the market into kind 1 and type 2 diabetes, with type 1 conserving a widespread proportion because of rising self-control focus and the increasing quantity of insulin-dependent sufferers. Distribution channels encompass sanatorium pharmacies, which lead because of clean access and procurement, and retail & online pharmacies, anticipated to grow swiftly as purchaser possibilities shift toward convenience.

The North America region led the smart insulin pens market by benefitting a size of USD 311.2 million in 2023 due to the increasing adoption of connected insulin pens and the drastically higher product prices in the U.S. In comparison to other countries.

The leading players in the Smart Insulin Pens market significantly shape its growth trajectory and set industry standards. These key players, including Novo Nordisk A/S (Denmark), Medtronic (Ireland), Ypsomed AG (Switzerland), Emperra GmbH (Germany), Pendiq (Germany), Jiangsu Deflu Medical Device Co. (China), Cambridge Consultants Ltd. (U.K.), and Diabnext (France), contribute to a competitive landscape that drives innovation and market advancement. Their ongoing efforts in product development and technological enhancements are pivotal in meeting the rising demand for smart insulin delivery solutions.

In June 2023, Novo Nordisk A/S revealed its plans to collect Biocorp, a French medical gadgets corporation. This acquisition is intended to leverage Biocorp’s era and information to grow a new related insulin pen.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 11.1% from 2024-2032

Unit Value (USD million)

Segmentation By Connectivity

Bluetooth

Near Field Communication (NFC)

By Indication

Type 1 Diabetes

Type 2 Diabetes

By Distribution Channel

Hospital Pharmacies

Retail & Online Pharmacies

By Region

North America (By Connectivity, Indication, Distribution Channel, and Country)
  • U.S. (By Indication)
  • Canada (By Indication)
Europe (By Connectivity, Indication, Distribution Channel, and Country)
  • Germany (By Indication)
  • U.K. (By Indication)
  • France (By Indication)
  • Italy (By Indication)
  • Spain (By Indication)
  • Scandinavia (By Indication)
  • Rest of Europe (By Indication)
Asia Pacific (By Connectivity, Indication, Distribution Channel, and Country)
  • China (By Indication)
  • India (By Indication)
  • Japan (By Indication)
  • Australia (By Indication)
  • Southeast Asia (By Indication)
  • Rest of the Asia Pacific (By Indication)
Rest of the World (By Connectivity, Indication, and Distribution Channel)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

125 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Diabetes, By Key Countries, 2023
4.2. New Product Launches, By Key Players
4.3. Technological Advancements In Smart Insulin Pens
4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships
4.5. Impact of COVID-19 on the Global Smart Insulin Pens Market
5. Global Smart Insulin Pens Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Connectivity
5.1.1. Bluetooth
5.1.2. Near Field Communication (NFC)
5.2. Market Analysis, Insights and Forecast – By Indication
5.2.1. Type 1 Diabetes
5.2.2. Type 2 Diabetes
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1. Hospital Pharmacies
5.3.2. Retail & Online Pharmacies
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Rest of the World
6. North America Smart Insulin Pens Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Connectivity
6.1.1. Bluetooth
6.1.2. Near Field Communication (NFC)
6.2. Market Analysis, Insights and Forecast – By Indication
6.2.1. Type 1 Diabetes
6.2.2. Type 2 Diabetes
6.3. Market Analysis, Insights and Forecast – By Distribution Channel
6.3.1. Hospital Pharmacies
6.3.2. Retail & Online Pharmacies
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.1.1. By Indication
6.4.2. Canada
6.4.2.1. By Indication
7. Europe Smart Insulin Pens Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Connectivity
7.1.1. Bluetooth
7.1.2. Near Field Communication (NFC)
7.2. Market Analysis, Insights and Forecast – By Indication
7.2.1. Type 1 Diabetes
7.2.2. Type 2 Diabetes
7.3. Market Analysis, Insights and Forecast – By Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. Retail & Online Pharmacies
7.4. Market Analysis, Insights and Forecast – By County/ Sub-region
7.4.1. Germany
7.4.1.1. By Indication
7.4.2. U.K.
7.4.2.1. By Indication
7.4.3. France
7.4.3.1. By Indication
7.4.4. Italy
7.4.4.1. By Indication
7.4.5. Spain
7.4.5.1. By Indication
7.4.6. Scandinavia
7.4.6.1. By Indication
7.4.7. Rest of Europe
7.4.7.1. By Indication
8. Asia Pacific Smart Insulin Pens Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Connectivity
8.1.1. Bluetooth
8.1.2. Near Field Communication (NFC)
8.2. Market Analysis, Insights and Forecast – By Indication
8.2.1. Type 1 Diabetes
8.2.2. Type 2 Diabetes
8.3. Market Analysis, Insights and Forecast – By Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Retail & Online Pharmacies
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. China
8.4.1.1. By Indication
8.4.2. India
8.4.2.1. By Indication
8.4.3. Japan
8.4.3.1. By Indication
8.4.4. Australia
8.4.4.1. By Indication
8.4.5. Southeast Asia
8.4.5.1. By Indication
8.4.6. Rest of Asia Pacific
8.4.6.1. By Indication
9. Rest of the World Smart Insulin Pens Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Connectivity
9.1.1. Bluetooth
9.1.2. Near Field Communication (NFC)
9.2. Market Analysis, Insights and Forecast – By Indication
9.2.1. Type 1 Diabetes
9.2.2. Type 2 Diabetes
9.3. Market Analysis, Insights and Forecast – By Distribution Channel
9.3.1. Hospital Pharmacies
9.3.2. Retail & Online Pharmacies
10. Competitive Analysis
10.1. Global Market Share Analysis (2023)
10.2. Company Profiles
10.2.1. Novo Nordisk A/S
10.2.1.1. Overview
10.2.1.2. Products & Services
10.2.1.3. SWOT Analysis
10.2.1.4. Recent Developments
10.2.1.5. Strategies
10.2.1.6. Financials (Based on Availability)
10.2.2. Medtronic
10.2.2.1. Overview
10.2.2.2. Products & Services
10.2.2.3. SWOT Analysis
10.2.2.4. Recent Developments
10.2.2.5. Strategies
10.2.2.6. Financials (Based on Availability)
10.2.3. Ypsomed AG
10.2.3.1. Overview
10.2.3.2. Products & Services
10.2.3.3. SWOT Analysis
10.2.3.4. Recent Developments
10.2.3.5. Strategies
10.2.3.6. Financials (Based on Availability)
10.2.4. Emperra GmbH
10.2.4.1. Overview
10.2.4.2. Products & Services
10.2.4.3. SWOT Analysis
10.2.4.4. Recent Developments
10.2.4.5. Strategies
10.2.4.6. Financials (Based on Availability)
10.2.5. Pendiq
10.2.5.1. Overview
10.2.5.2. Products & Services
10.2.5.3. SWOT Analysis
10.2.5.4. Recent Developments
10.2.5.5. Strategies
10.2.5.6. Financials (Based on Availability)
10.2.6. Jiangsu Deflu Medical Device Co.
10.2.6.1. Overview
10.2.6.2. Products & Services
10.2.6.3. SWOT Analysis
10.2.6.4. Recent Developments
10.2.6.5. Strategies
10.2.6.6. Financials (Based on Availability)
10.2.7. Cambridge Consultants Ltd
10.2.7.1. Overview
10.2.7.2. Products & Services
10.2.7.3. SWOT Analysis
10.2.7.4. Recent Developments
10.2.7.5. Strategies
10.2.7.6. Financials (Based on Availability)
10.2.8. Diabnext
10.2.8.1. Overview
10.2.8.2. Products & Services
10.2.8.3. SWOT Analysis
10.2.8.4. Recent Developments
10.2.8.5. Strategies
10.2.8.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us